Emyria was recently featured in the Australian Financial Review as part of an article highlighting the recent investments of Andrew Forrest’s Tattarang-owned Tenmile.

As reported, the Forrests invested $5 million in Emyria in November, and Tenmile Executive Chairman Dr Steve Burnell confirmed a “…strong interest in the work being done by Emyria.”

Read the article here:
Forrest has a new focus on a $250m health tech fund that looks at medical MDMA